AASOX Fees and Costs — Alger Small Cap Growth Portfolio, Class I-2
Data updated: 2026-08-27
The net expense ratio is 0.97%: a 0.81% management fee plus 0.16% other expenses. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $103K in broker commissions, 0.0737% of average net assets, and portfolio turnover was 41%.
AASOX Fees and Expenses
Annual operating expenses and sales charges of AASOX. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.81% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.16% |
| Gross expense ratio | 0.97% |
| Fee waiver | — |
| Net expense ratio | 0.97% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
AASOX Costs Over Time
On $10,000 invested in AASOX, assuming 5% a year before costs, total costs come to $652 over 5 years, cutting the return by 1.10% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.97%) | $102 | $318 | $551 |
| Trading costs (broker commissions) | $8 | $24 | $42 |
| Lost growth on money paid in costs | $0 | $17 | $60 |
| Total costs | $110 | $359 | $652 |
| Value after costs | $10,390 | $11,218 | $12,111 |
| Impact on return, per year | 1.10% | 1.10% | 1.10% |
AASOX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0737%
- Total broker commissions: $103K
- Bought from dealers (principal trades, not a cost): $6.2M
- Portfolio turnover (prospectus): 41%
- Securities lending: none during the year
AASOX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | $26K | 27.64% |
| Pershing LLC | $20K | 21.07% |
| Fred Alger & Company, LLC | $16K | 17.31% |
| NATIONAL FINANCIAL SERVICES LLC | $12K | 12.75% |
| LPS Capital LLC | $6K | 6.17% |
| MORGAN STANLEY & CO. LLC | $4K | 4.17% |
| GOLDMAN SACHS & CO. LLC | $3K | 3.24% |
| Raymond James & Associates, Inc. | $3K | 2.86% |
| Stifel, Nicolaus & Company, Incorporated | $3K | 2.71% |
| RBC CAPITAL MARKETS, LLC | $2K | 2.08% |
AASOX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| J.P. Morgan Securities LLC | $1.6M | 26.51% |
| Goldman Sachs & Co. LLC | $1.4M | 22.35% |
| Jefferies & Company Inc | $1.0M | 16.89% |
| Disruptive Technology Solutions LLC | $770K | 12.41% |
| MORGAN STANLEY & CO. LLC | $635K | 10.22% |
| Fred Alger & Company, LLC | $348K | 5.61% |
| PERSHING LLC | $294K | 4.74% |
| Merrill Lynch Pierce Fenner & Smith Inc | $41K | 0.66% |
| CitiGroup Global Markets Inc. | $38K | 0.61% |
| Prosetta Biosciences, Inc. | $2 | 0.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.